Evidence map›Paper›PMID 39008530›Full record

ArticleDiabetes care2024

Bidirectional Associations Between Mental Health Disorders and Chronic Diabetic Complications in Individuals With Type 1 or Type 2 Diabetes.

Maya Watanabe, Evan L Reynolds, Mousumi Banerjee, Morten Charles, Kara Mizokami-Stout, Dana Albright, Lynn Ang, Joyce M Lee, Rodica Pop-Busui, Eva L Feldman and 1 more

Abstract read
In one paragraph

Article in Diabetes care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maya WatanabeDepartment of Biostatistics, University of Michigan, Ann Arbor, MI.ORCID 0009-0007-3309-2852
Evan L ReynoldsDepartment of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI.ORCID 0000-0002-0138-8436
Mousumi BanerjeeDepartment of Biostatistics, University of Michigan, Ann Arbor, MI.
Morten CharlesDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Kara Mizokami-StoutDivision of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
Dana AlbrightDepartment of Health Services and Informatics Research, Parkview Health, Fort Wayne, IN.
Lynn AngDivision of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.ORCID 0000-0001-7133-9886
Joyce M LeeSusan B. Meister Child Health Evaluation and Research Center, Division of Pediatric Endocrinology, Department of Pediatrics, University of Michigan, Ann Arbor, MI.
Rodica Pop-BusuiDivision of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-2042-1350
Eva L FeldmanDepartment of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI.ORCID 0000-0002-9162-2694
Brian C CallaghanDepartment of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI.ORCID 0000-0002-8885-6748

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Scott Soleimanpour · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joyce Lee · 2010 to 2026
$20.3M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
NIDDK Diabetic Foot Consortium Clinical Research UnitU01DK119083 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RODICA BUSUI (POP-BUSUI), Crystal Murray Holmes · 2018 to 2026
$5.5M
Schwann Cell Senescence and the Secretome Provide a Unifying Mechanism for the Onset and Progression of Diabetic NeuropathyR01DK130913 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eva Lucille Feldman, Junguk Hur · 2022 to 2026
$3.3M
The Effect of High Intensity Interval Training and Surgical Weight Loss On Distal Symmetric Polyneuropathy OutcomesR01DK115687 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CALLAGHAN, BRIAN CHRISTOPHER · 2018 to 2022
$3.1M
Targeting Inflammation with Salsalate as a Novel Therapy for Diabetic NeuropathyR01DK107956 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BUSUI (POP-BUSUI), RODICA, FELDMAN, EVA LUCILLE · 2016 to 2020
$3.0M
Effects of Fish Oil ± Salsalate on the Omega-3 Index and the Circulating Lipodome of Omega-3 Polyunsaturated Fatty Acid Metabolites in Patients with Type 2 Diabetes and Diabetic NeuropathyR01DK126837 · NIDDK · UNIVERSITY OF IOWA · PI BUSUI (POP-BUSUI), RODICA, YOREK, MARK A. · 2022 to 2025
$2.5M
Identifying lifelong factors that impact brain health and outcomes in type 1 diabetes: The Cognition and Longitudinal Assessments of Risk Factors over 30 Years (CLARiFY) Diabetes Complications StudyR01DK129320 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FELDMAN, EVA LUCILLE · 2021 to 2025
$2.3M
Target self-regulation to promote adherence and health behaviors in childrenUH3HD087979 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FREDERICKS, EMILY MACDONALD, MILLER, ALISON L · 2018 to 2019
$2.1M
Support to Adopt and Retain Technology (StART) CGM: A pilot study to support continuous glucose monitoring in primary careK23DK131296 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kara R Mizokami-Stout · 2022 to 2026
$970k
Trial to Assess Chelation Therapy 2 (TACT2) DCCUG3AT009150 · NCCIH · DUKE UNIVERSITY · PI ANSTROM, KEVIN J, MARK, DANIEL B · 2015 to 2016
$932k
Breakthrough T1D 5-COE-2019-861-S-BElizabeth Weiser Caswell Diabetes Institute at the University of MichiganGerber Foundation N030009JDRF Center of ExcellenceMDRC P30DK020572Michigan Center for Diabetes Translational Research P30DK092926Michigan Nutrition Obesity Research Center, Medical School, University of Michigan P30DK089503NCCIH NIH HHS UG3 AT009150NICHD NIH HHS UH3 HD087979NIDDK NIH HHS K23 DK131296NIDDK NIH HHS K99 DK129785NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK089503NIDDK NIH HHS P30 DK092926NIDDK NIH HHS P30DK092926NIDDK NIH HHS R01 DK107956NIDDK NIH HHS R01 DK115687NIDDK NIH HHS R01 DK126837NIDDK NIH HHS R01 DK129320NIDDK NIH HHS R01 DK130913NIDDK NIH HHS U01 DK119083NIH HHS P30DK092926
6 · The paper itself

Abstract

objectiveTo determine bidirectional associations between the timing of chronic diabetes complications (CDCs) and mental health disorders (MHDs) in individuals with type 1 or type 2 diabetes. RESEARCH DESIGN AND

methodsWe used a nationally representative health care claims database to identify matched individuals with type 1 or 2 diabetes or without diabetes using a propensity score quasirandomization technique stratified by age (0-19, 20-39, 40-59, and ≥60 years). CDCs and MHDs were identified using ICD-9/10 codes. We fit Cox proportional hazards models with time-varying diagnoses of CDCs or MHDs to investigate their association with the hazard of developing MHDs or CDCs, respectively.

resultsFrom 2001 to 2018, a total of 553,552 individuals were included (44,735 with type 1 diabetes, 152,187 with type 2 diabetes, and 356,630 without diabetes). We found that having a CDC increased the hazard of developing an MHD (hazard ratio [HR] 1.9-2.9; P < 0.05, with higher HRs in older age strata), and having an MHD increased the hazard of developing a CDC (HR 1.4-2.5; P < 0.05, with the highest HR in age stratum 0-19 years). In those aged <60 years, individuals with type 1 diabetes were more likely to have CDCs, whereas individuals with type 2 diabetes were more likely to have MHDs. However, the relationship between CDCs and MHDs in either direction was not affected by diabetes type (P > 0.05 for interaction effects).

conclusionsWe found a consistent bidirectional association between CDCs and MHDs across the life span, highlighting the important relationship between CDCs and MHDs. Prevention and treatment of either comorbidity may help reduce the risk of developing the other.

Indexed as

Diabetes ComplicationsDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Mental DisordersAdolescentAdultAgedChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedProportional Hazards Models

Identifiers

PMID39008530
PMCPMC11362112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.